Detalhe da pesquisa
1.
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity.
bioRxiv
; 2023 Aug 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37662390
2.
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity.
Res Sq
; 2023 Sep 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37790523
3.
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy.
J Clin Invest
; 133(15)2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37526080
4.
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections.
Blood Cancer Discov
; 4(2): 106-117, 2023 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36511813
5.
Tregs protect against combination checkpoint blockade toxicity induced by TPH and B cell interactions.
J Clin Invest
; 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38696264